Paloma Partners’s Inspire Medical Systems INSP Stock Holding History

Paloma Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,032	Closed	-$205K	–	822
2023 Q3	$205K	Buy	+1,032	New	+$260K	0.01%	587
2022 Q3	–	Sell	-1,950	Closed	-$356K	–	1170
2022 Q2	$356K	Buy	+1,950	New	+$389K	0.01%	722
2022 Q1	–	Sell	-1,086	Closed	-$248K	–	1992
2021 Q4	$250K	Buy	+1,086	New	+$265K	﹤0.01%	1504
2021 Q3	–	Sell	-6,415	Closed	-$1.24M	–	1473
2021 Q2	$1.24M	Buy	+6,415	New	+$1.27M	0.02%	551
2021 Q1	–	Sell	-3,140	Closed	-$591K	–	2185
2020 Q4	$591K	Buy	+3,140	New	+$513K	0.02%	821

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Paloma Partners's INSP Position: Q4 2023 in Review

Paloma Partners sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 1,032 shares — an estimated $205K sold.

Paloma Partners first reported a position in INSP in Q4 2020 and held it in 5 quarters. The position peaked at $1.24M in Q2 2021. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

Paloma Partners reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
Paloma Partners sold 1,032 Inspire Medical Systems shares in Q4 2023, an estimated $205K.
Paloma Partners first reported a position in Inspire Medical Systems in Q4 2020 and held it in 5 quarters.
Paloma Partners's Inspire Medical Systems position peaked at $1.24M in Q2 2021.
343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Paloma Partners's 13F filing for Q4 2023, filed 14 Feb 2024.